Early predictors of efficacy of biological therapy for psoriasis in children

Early predictors of efficacy of biological therapy for psoriasis in children

.

Bibliographic Details
Main Authors:	D. G. Kuptsova, S. V. Petrichuk, N. N. Murashkin, T. V. Radigina, O. V. Kurbatova
Format:	Article
Language:	Russian
Published:	Association of Paediatric Allergists and Immunologists of Russia (APAIR) 2023-04-01
Series:	Аллергология и Иммунология в Педиатрии
Subjects:	дети псориаз th17 treg mdscs клетки памяти биологическая терапия
Online Access:	https://adair.elpub.ru/jour/article/view/38

Similar Items

Biological Therapy Survivability in Children with Psoriasis: Cohort Study
by: Roman A. Ivanov, et al.
Published: (2021-11-01)

Content of CD4<sup>+</sup>T cell subpopulations in predicting the efficacy of biological therapy for psoriasis in children
by: D. G. Kuptsova, et al.
Published: (2023-06-01)

BIOLOGIC THERAPY IN PEDIATRIC RHEUMATOLOGY
by: A. A. Baranov, et al.
Published: (2011-01-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Pathogenic aspects of treatment of psoriatic patients
by: V. V. Chikin, et al.
Published: (2017-08-01)

Immune pathogenesis of psoriasis
by: V. R. Khairutdinov, et al.
Published: (2017-08-01)

Management of Children with Psoriasis During the COVID-19 Pandemic
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

Management of Moderate and Severe Forms of Psoriasis in Children: New Opportunities of Genetically Engineered Biologic Drugs
by: Leyla S. Namazova-Baranova, et al.
Published: (2021-11-01)

Psoriasis Comorbidities in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Psoriasis in Pediatrics
by: Andrey L. Bakulev, et al.
Published: (2020-12-01)

Polyethylene Glycol Ointment Alleviates Psoriasis-Like Inflammation Through Down-Regulating the Function of Th17 Cells and MDSCs
by: Yan Lu, et al.
Published: (2021-03-01)

EHF-therapy in complex treatment of psorias
by: V. S. Dmitruk
Published: (2005-12-01)

Uveitis associated with juvenile idiopathic arthritis
by: L. A. Galstyan, et al.
Published: (2019-05-01)

Efficacy of the combined therapy with etanercept and methotrexat at the female patient with generalized pustular psoriasis and arthritis psoriasis after the therapeutic failure of two the TNF-α receptor inhibitors. Case study
by: V. V. Vustina, et al.
Published: (2017-08-01)

Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
by: A. V. Martynova, et al.
Published: (2022-02-01)

The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice
by: I. M. Marusenko, et al.
Published: (2021-06-01)

Pathogenetic mechanisms of biological agents in managing of relapsing polychondritis
by: E. G. Khaleva, et al.
Published: (2018-07-01)

The use of guselkumab in psoriatic arthritis: evidence from real clinical practice
by: N. V. Nekrasova, et al.
Published: (2021-12-01)

Administration Details of Genetically Engineered Biologic Drug (Ustekinumab) in Children with Psoriasis and Comorbid Metabolic Syndrome or in Case of Previous Biological Therapy Failure: Case Studies
by: Roman A. Ivanov, et al.
Published: (2022-11-01)

PSORIASIS OF THE SCALP: METHODS OF TREATMENT AND CARE
by: A. I. Ermilova, et al.
Published: (2013-05-01)

Influence of Melatonin on the state of immunity at psoriasis
by: V. S. Dmitruk, et al.
Published: (2009-08-01)

Multiple subsets of regulatory T-cells
by: S. V. Kupriyanov, et al.
Published: (2020-10-01)

MANAGEMENT OF A PATIENT WITH SEVERE COURSE OF PSORIATIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-05-01)

ISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS IN PATIENT SUFFERING FROM PLAQUE PSORIASIS: A CASE REPORT
by: L. F. Znamenskaya, et al.
Published: (2017-08-01)

T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis
by: A. V. Martynova, et al.
Published: (2021-04-01)

Analysis of the range of medications for treatment of psoriasis
by: E V Kaverina
Published: (2016-12-01)

Skin microbiota in patients with psoriasis vulgaris and pustular psoriasis
by: E. A. Bakhlykova, et al.
Published: (2017-08-01)

Efficacy of ozonetherapy in the complex treatment of psoriasis
by: V V Baityakov
Published: (2011-06-01)

The immunomodulation role of Th17 and Treg in renal transplantation
by: Dan-Lei Huang, et al.
Published: (2023-02-01)

A case of generalized pustular psoriasis
by: V. A. Oklopkov, et al.
Published: (2017-08-01)

Evaluation of effectiveness and safety of Etanercept in children with Juvenile psoriatic arthritis
by: K. V. Aleksanyan, et al.
Published: (2020-09-01)

T CELL EFFECTOR AND REGULATORY SUBSETS, DIFFERENTIATING BETWEEN ACTIVE AND LATENT MTB INFECTION
by: Yana Todorova, et al.
Published: (2019-12-01)

Informative value of laboratory markers in assessing the stage of liver fibrosis in children with type 1 autoimmune hepatitis
by: O. V. Kurbatova, et al.
Published: (2023-04-01)

METHODS OF ASSESSMENT OF THE RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS IN NEUTRON THERAPY
by: V. A. Lisin
Published: (2017-11-01)

AGE-DEPENDENT CHANGES OF T-REGULATORY AND Th17 SUBSET LEVELS IN PERIPHERAL BLOOD FROM HEALTHY HUMANS
by: A. P. Toptygina, et al.
Published: (2017-08-01)

Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2017-04-01)

The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)

Endothelial dysfunction and its treatment in psoriasis patients
by: Yu. M. Shtoda, et al.
Published: (2017-08-01)

Имунологичен профил и клинични корелации при пациентка с пристъпно-ремитентна множествена склероза, провеждаща лечение с Fingolimod
by: Marina Ivanova, et al.
Published: (2019-12-01)